RSPH · Invesco S&P 500 Equal Weight Health Care ETF

Equity fundTracks an index0.40% fee$875mSince Jan 4, 2010Fund page at the issuer ↗SEC filings ↗

RSPH tracks an index and returned +22.3% over the past year.

+22.3%
Total return, 1 year
0.40%
Expense ratio
64
Holdings
−3.6%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026+6.2%+3.6%+2.6 pts+0.9 pts
6M Apr 2 – Oct 2, 2026+21.4%+17.9%+3.5 pts−7.0 pts
1Y Oct 2, 2025 – Oct 2, 2026+22.3%+16.2%+6.1 pts−2.0 pts
3Y Oct 3, 2023 – Oct 2, 2026+38.6%+89.3%−50.6 pts−76.1 pts
Since listing Jan 4, 2010 – Oct 2, 2026+607.2%+813.0%−205.8 pts−1154.7 pts

RSPH over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

RSPH top ten by weight, 19.2% of its 64 equity positions, from the holdings published by its issuer for Oct 3, 2026. An index fund holds what the index holds, so this is the index. Source: the issuer’s own daily file.

Moderna Inc MRNA 2.31%
Illumina Inc ILMN 2.20%
Revvity Inc RVTY 2.02%
West Pharmaceutical Services Inc WST 1.79%
Viatris Inc VTRS 1.76%
Waters Corp WAT 1.73%

In plain words

RSPH tracks an index. Over the year to Oct 2, 2026 it returned +22.3% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.40% a year. By its holdings published by its issuer for Oct 3, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 64 positions, with the top ten at 19.2%. It sat 3.6% below its high of Aug 19, 2026 on Oct 2, 2026.
What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Aug 27, 2026)0.40%
Price$36.62
Listed sinceJan 4, 2010
Net assets (the issuer’s daily holdings, added up, as of Oct 3, 2026)$875m
Below its high (ETFIQ)−3.6%
Holdings64
Top ten weight19.2%
Holdings published for (the issuer’s daily file)Oct 3, 2026
Already in the S&P 500, by weight (ETFIQ)100.0%
Active share vs the S&P 500 (ETFIQ)91.1%
Already in the Nasdaq-100, by weight (ETFIQ)13.4%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about RSPH

How has RSPH performed?
Over the year to Oct 2, 2026, RSPH returned +22.3% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is +38.6%.
What does RSPH cost?
The prospectus expense ratio is 0.40% a year.
What does RSPH hold?
64 positions as published by its issuer for Oct 3, 2026, with the top ten at 19.2% of the fund. 100% of its weight is in stocks the S&P 500 also holds.
How far is RSPH below its high?
3.6% below its high of Aug 19, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, RSPH and S&P 500Tiingo end-of-day · Oct 2, 2026
Net assets, $875mThe issuer’s daily holdings, added up · Oct 3, 2026

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

Cite this page

ETFIQ, RSPH, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/rsph

Free to use with attribution; the underlying files are at Open data.